Stocks recently featured in the blog include Eli Lilly LLY, Charter Communications CHTR, Eaton ETN, Autodesk ADSK and Cypress Semiconductor CY.The Zacks analyst believes that in 2020, Lilly’s revenue growth is likely to be driven by higher demand for newer drugs like Trulicity, Jardiance, Taltz, Verzenio, Basaglar, Emgality as well as newly launched Baqsimi and Reyvow.